Hester Biosciences has informed that it enclosed press release titled 'Hester Biosciences Limited Q2 and H1 FY22 Results- Revenue up by 6% and 24%, Net Profit up by 16% and 35%, for Q2 and H1 FY22 - Appointment of additional Directors on the Board'.
The above information is a part of company’s filings submitted to BSE.